John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Amdocs
DOX
$6.48B
| $3.24M | 0.01% |
40,819
-22,060
| -35% | -$1.87M |
|
927
BlackRock TCP Capital
TCPC
$342M
| $3.24M | 0.01% |
296,730
-90,452
| -23% | -$1.18M |
|
|
HEES
928
DELISTED
H&E Equipment Services
HEES
| $3.23M | 0.01% |
114,143
+14,173
| +14% | +$446K |
|
929
ADMA Biologics
ADMA
$2.14B
| $3.22M | 0.01% |
1,325,982
+764,545
| +136% | +$1.83M |
|
930
Enerpac Tool Group
EPAC
$1.9B
| $3.22M | 0.01% |
180,569
+153,866
| +576% | +$2.99M |
|
|
DCT
931
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $3.2M | 0.01% |
+270,394
| New | +$3.58M |
|
932
Amkor Technology
AMKR
$11.9B
| $3.19M | 0.01% |
+187,199
| New | +$3.6M |
|
|
VTYX
933
DELISTED
Ventyx Biosciences
VTYX
| $3.19M | 0.01% |
+91,395
| New | +$2.02M |
|
934
Reinsurance Group of America
RGA
$16B
| $3.18M | 0.01% |
25,271
-5,397
| -18% | -$664K |
|
935
Castle Biosciences
CSTL
$1.02B
| $3.17M | 0.01% |
121,548
-27,881
| -19% | -$782K |
|
936
Innoviz Technologies
INVZ
$101M
| $3.16M | 0.01% |
605,905
+544,105
| +880% | +$2.61M |
|
937
Paysafe
PSFE
$347M
| $3.16M | 0.01% |
190,670
-36,817
| -16% | -$823K |
|
938
Zillow
ZG
$8.53B
| $3.15M | 0.01% |
+110,077
| New | +$3.84M |
|
939
Petco
WOOF
$822M
| $3.15M | 0.01% |
281,898
-186,648
| -40% | -$2.73M |
|
940
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
| $3.12M | 0.01% |
17,400
+6,300
| +57% | +$1.26M |
|
941
NiSource
NI
$19.6B
| $3.12M | 0.01% |
+123,806
| New | +$3.65M |
|
942
Aldeyra Therapeutics
ALDX
$91.7M
| $3.1M | 0.01% |
581,439
-24,629
| -4% | -$148K |
|
943
Trinity Capital Inc
TRIN
$1.76B
| $3.1M | 0.01% |
247,250
+24,121
| +11% | +$356K |
|
944
Simpson Manufacturing
SSD
$7.69B
| $3.1M | 0.01% |
+39,490
| New | +$3.82M |
|
945
World Kinect Corp
WKC
$1.82B
| $3.08M | 0.01% |
131,623
+62,876
| +91% | +$1.56M |
|
|
VMRK
946
Vivmark Residential
VMRK
$25.5B
| $3.08M | 0.01% |
+45,860
| New | +$3.39M |
|
947
Privia Health
PRVA
$2.68B
| $3.08M | 0.01% |
+90,500
| New | +$3.35M |
|
|
SWCH
948
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $3.07M | 0.01% |
91,237
-607,183
| -87% | -$20.6M |
|
949
Omnicell
OMCL
$1.58B
| $3.07M | 0.01% |
+35,298
| New | +$3.71M |
|
|
CFLT
950
DELISTED
Confluent
CFLT
| $3.07M | 0.01% |
+129,162
| New | +$3.48M |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.